ASX:FIJFiji Kava Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Fiji Kava Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day RangeA$0.07MA: A$0.09▼A$0.1152-Week Range N/AVolume282,363 shsAverage VolumeN/AMarket Capitalization$5.23 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines Fiji Kava Limited, a biotechnology company, produces and sells kava extract capsules for relaxation. It also focuses on the research and development into the therapeutic use of kava products; and production and sale of kava supplements and complimentary medicines. Fiji Kava Limited is based in Subiaco, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Fiji Kava. Previous Next 2.6 Community Rank Outperform VotesFiji Kava has received 15 “outperform” votes. (Add your “outperform” vote.)Underperform VotesFiji Kava has received 14 “underperform” votes. (Add your “underperform” vote.)Community SentimentFiji Kava has received 51.72% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Fiji Kava and other stocks. Vote “Outperform” if you believe FIJ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FIJ will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldFiji Kava does not currently pay a dividend.Dividend GrowthFiji Kava does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Fiji Kava insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Fiji Kava is -0.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fiji Kava is -0.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.52 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolASX:FIJ Previous Symbol CUSIPN/A CIKN/A Webfijikava.com Phone61 8 6489 1600Debt Debt-to-Equity Ratio98.38 Current Ratio1.91 Quick Ratio1.40Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$329,656.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.03 Book ValueA$0.01 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares95,275,600Market Cap$5.23 million Next Earnings DateN/A OptionableNot Optionable Receive FIJ News and Ratings via Email Sign-up to receive the latest news and ratings for FIJ and its competitors with MarketBeat's FREE daily newsletter. Fiji Kava (ASX:FIJ) Frequently Asked Questions Has Fiji Kava been receiving favorable news coverage? Headlines about FIJ stock have been trending neutral recently, according to InfoTrie Sentiment. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Fiji Kava earned a daily sentiment score of 0.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an impact on the stock's share price in the near future. View the latest news about Fiji Kava. Who are some of Fiji Kava's key competitors? Some companies that are related to Fiji Kava include Exopharm (EX1), AorTech International (AOR), Galena Biopharma (SLS), BTC Health (BTC), C4X Discovery (C4XD), Regeneus (RGS), Nyrada (NYR), Cellmid (CDY), Prescient Therapeutics (PTX), Nuformix (NFX), Inhibitor Therapeutics (INTI), Destiny Pharma (DEST), Agronomics (ANIC), Biocardia (BCDA) and CAN-FITE BIOPHA/S (CANF). View all competitors. Who are Fiji Kava's key executives? Fiji Kava's management team includes the following people: Mr. Zane Yoshida, Managing Director & DirectorProf. Stephen Copplin, Exec. DirectorProf. Jerome Sarris, Member Scientific Advisory Board & Chief ScientistMr. James Richard Stephenson C.M.A., M.A.I.C.D., M.B.A., CMA, P.Geo, FCIS, MBA, Non-Exec. Director & Company Sec. (Age 53) What is Fiji Kava's stock symbol? Fiji Kava trades on the ASX under the ticker symbol "FIJ." How big of a company is Fiji Kava? Fiji Kava has a market capitalization of $0.00 and generates $329,656.00 in revenue each year. What is Fiji Kava's official website? The official website for Fiji Kava is fijikava.com. How can I contact Fiji Kava? The company can be reached via phone at 61 8 6489 1600. This page was last updated on 7/5/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
